922
Views
24
CrossRef citations to date
0
Altmetric
Review

The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy

, , &
Pages 83-92 | Published online: 11 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (24)

David Bolaji Akinbo & Olutayo Ifedayo Ajayi. (2023) Thrombotic Pathogenesis and Laboratory Diagnosis in Cancer Patients, An Update. International Journal of General Medicine 16, pages 259-272.
Read now
Yogesh Singh, Kulkarni Swanand Sanjay, Pradeep Kumar, Satwinder Singh & Suresh Thareja. (2023) Molecular dynamics and 3D-QSAR studies on indazole derivatives as HIF-1α inhibitors. Journal of Biomolecular Structure and Dynamics 41:8, pages 3524-3541.
Read now
Sanchit Gandhi, Ashish Bhushan, Unmesh Shukla, Amit Pundir, Sanjeev Singh & Tapasya Srivastava. (2023) Downregulation of lncRNA SNHG1 in hypoxia and stem cells is associated with poor disease prognosis in gliomas. Cell Cycle 22:9, pages 1135-1153.
Read now
Shreya Chowdhury, Ramani Ramchandran, Sean P. Palecek, Suehelay Acevedo-Acevedo & Erin Bishop. (2023) Sucrose Nonfermenting-Related Kinase Expression Is Related to a Metabolic Switch in Ovarian Cancer Cells That Results in Increased Fatty Acid Oxidation. Cancer Investigation 41:4, pages 330-344.
Read now
James Draper, Jodi Alexander, Rohini M. Nair, Nicole Scullion, Revu V. L. Narayana, Karen Aughton, Anne Herrmann, Geeta K. Vemuganti, Helen Kalirai & Sarah E. Coupland. (2023) Using the Chick Embryo Model to Examine the Effects of Hypoxia Pre-conditioning of Uveal Melanoma Cells on Tumor Growth and Metastasis. Current Eye Research 48:4, pages 408-415.
Read now
Mehak, Rajkumar P Thummer & Lalit M. Pandey. (2023) Surface modified iron-oxide based engineered nanomaterials for hyperthermia therapy of cancer cells. Biotechnology and Genetic Engineering Reviews 0:0, pages 1-47.
Read now
Mateusz Kciuk, Adrianna Gielecińska, Somdutt Mujwar, Mariusz Mojzych, Beata Marciniak, Rafał Drozda & Renata Kontek. (2022) Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 1278-1298.
Read now
Muhammad Umair Amin, Sajid Ali, Muhammad Yasir Ali, Dominik C. Fuhrmann, Imran Tariq, Benjamin S. Seitz, Eduard Preis, Jana Brüßler, Bernhard Brüne & Udo Bakowsky. (2022) Co-delivery of carbonic anhydrase IX inhibitor and doxorubicin as a promising approach to address hypoxia-induced chemoresistance. Drug Delivery 29:1, pages 2072-2085.
Read now
Sakunie Sawai, Pooi-Fong Wong & Thamil Selvee Ramasamy. (2022) Hypoxia-regulated microRNAs: the molecular drivers of tumor progression. Critical Reviews in Biochemistry and Molecular Biology 57:4, pages 351-376.
Read now
Kartik Hariharan, Parth Patel & Tejal Mehta. (2022) Surface modifications of gold nanoparticles: stabilization and recent applications in cancer therapy. Pharmaceutical Development and Technology 27:6, pages 665-683.
Read now
Wanessa Fernanda Altei, Bianca Cruz Pachane, Cristiano Souza, Márcia Maria Chiquitelli Marques & Heloisa Selistre-de-Araújo. (2022) New insights into the discovery of drugs for triple-negative breast cancer metastasis. Expert Opinion on Drug Discovery 17:4, pages 365-376.
Read now
Joo-Hyung Lee, Feng Xiong & Wenbo Li. (2020) Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential. RNA Biology 17:11, pages 1550-1559.
Read now
Georgios Kareliotis, Ioanna Tremi, Myrsini Kaitatzi, Eleni Drakaki, Alexandros A. Serafetinides, Mersini Makropoulou & Alexandros G. Georgakilas. (2020) Combined radiation strategies for novel and enhanced cancer treatment. International Journal of Radiation Biology 96:9, pages 1087-1103.
Read now
Joanna Kruk, Katarzyna Kotarska & Basil H. Aboul-Enein. (2020) Physical exercise and catecholamines response: benefits and health risk: possible mechanisms. Free Radical Research 54:2-3, pages 105-125.
Read now
Anand Panchal, Pui Seto, Russell Wall, Brian J. Hillier, Ying Zhu, Jessica Krakow, Aakash Datt, Elizabeth Pongo, Andisheh Bagheri, Tseng-Hui T. Chen, Jeremiah D. Degenhardt, Patricia A. Culp, Danielle E. Dettling, Maia V. Vinogradova, Chad May & Robert B. DuBridge. (2020) COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumors. mAbs 12:1.
Read now
Chengcheng Zhu, Huafeng Ding, Junwen Yang, Yihui Zhou, Yonghong Luo, Suhua Shi, Ying Zhang, Yalan Wei & Guantai Ni. (2019) Downregulation of Proline Hydroxylase 2 and Upregulation of Hypoxia-Inducible Factor 1α are Associated with Endometrial Cancer Aggressiveness. Cancer Management and Research 11, pages 9907-9912.
Read now
Jinhua Zhang, Jing Si, Lu Gan, Cuixia Di, Yi Xie, Chao Sun, Hongyan Li, Menghuan Guo & Hong Zhang. (2019) Research progress on therapeutic targeting of quiescent cancer cells. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 2810-2819.
Read now
Michael I. Koukourakis & Alexandra Giatromanolaki. (2019) Warburg effect, lactate dehydrogenase, and radio/chemo-therapy efficacy. International Journal of Radiation Biology 95:4, pages 408-426.
Read now
Amirhosein Kefayat, Fatemeh Ghahremani, Hasan Motaghi, Soodabeh Rostami & Masoud A. Mehrgardi. (2019) Alive attenuated Salmonella as a cargo shuttle for smart carrying of gold nanoparticles to tumour hypoxic regions. Journal of Drug Targeting 27:3, pages 315-324.
Read now
Cecilia Arriagada, Patricio Silva & Vicente A. Torres. (2019) Role of glycosylation in hypoxia-driven cell migration and invasion. Cell Adhesion & Migration 13:1, pages 13-22.
Read now
Emily Bryer & David Henry. (2018) Chemotherapy-induced anemia: etiology, pathophysiology, and implications for contemporary practice. International Journal of Clinical Transfusion Medicine 6, pages 21-31.
Read now
Yu Xia, Lixia Jiang & Tianyu Zhong. (2018) The role of HIF-1α in chemo-/radioresistant tumors. OncoTargets and Therapy 11, pages 3003-3011.
Read now
Xiaoyan Chen, Ping Wang, Fei Guo, Xiangdong Wang, Juan Wang, Jinping Xu, Dexiao Yuan, Jianghong Zhang & Chunlin Shao. (2017) Autophagy enhanced the radioresistance of non-small cell lung cancer by regulating ROS level under hypoxia condition. International Journal of Radiation Biology 93:8, pages 764-770.
Read now